Literature DB >> 2958275

The E3/19K protein of adenovirus type 2 binds to the domains of histocompatibility antigens required for CTL recognition.

H G Burgert1, S Kvist.   

Abstract

The E3/19K protein of human adenovirus type 2 binds to HLA class I antigens and blocks their terminal glycosylation and cell surface expression. The nature of this interaction is non-covalent and involves neither disulfide bridges between the two molecules nor their carbohydrates. The murine H-2 Kd antigen associates with the E3/19K protein in a similar fashion to human HLA antigens whereas the allelic product H-2 Kk does not. Hybrid genes between the Kd and Kk alleles were constructed and their products were expressed in embryonic kidney cells together with the E3/19K protein. This allowed us to identify the alpha 1 and alpha 2 domains as the essential structures of the histocompatibility antigens for binding the viral protein. Interestingly, these domains are also crucial for T cell recognition. The implications for the evolution of adenoviruses and their ability to cause persistent infections are discussed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2958275      PMCID: PMC553591          DOI: 10.1002/j.1460-2075.1987.tb02466.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  47 in total

1.  The genomic map position of the adenovirus type 2 glycoprotein.

Authors:  S Ross; A J Levine
Journal:  Virology       Date:  1979-12       Impact factor: 3.616

2.  Complex splicing patterns of RNAs from the early regions of adenovirus-2.

Authors:  L T Chow; T R Broker; J B Lewis
Journal:  J Mol Biol       Date:  1979-10-25       Impact factor: 5.469

3.  A subcloning strategy for DNA sequence analysis.

Authors:  A M Frischauf; H Garoff; H Lehrach
Journal:  Nucleic Acids Res       Date:  1980-12-11       Impact factor: 16.971

4.  Nucleotide sequence of the EcoRI D fragment of adenovirus 2 genome.

Authors:  J Hérissé; G Courtois; F Galibert
Journal:  Nucleic Acids Res       Date:  1980-05-24       Impact factor: 16.971

Review 5.  Regulation of adenovirus gene expression.

Authors:  H Persson; L Philipson
Journal:  Curr Top Microbiol Immunol       Date:  1982       Impact factor: 4.291

6.  Major histocompatibility antigens: the human (HLA-A, -B, -C) and murine (H-2K, H-2D) class I molecules.

Authors:  H L Ploegh; H T Orr; J L Strominger
Journal:  Cell       Date:  1981-05       Impact factor: 41.582

7.  Multiple mRNA species for the precursor to an adenovirus-encoded glycoprotein: identification and structure of the signal sequence.

Authors:  H Persson; H Jörnvall; J Zabielski
Journal:  Proc Natl Acad Sci U S A       Date:  1980-11       Impact factor: 11.205

8.  Structures of the oligosaccharides of the glycoprotein coded by early region E3 of adenovirus 2.

Authors:  R Kornfeld; W S Wold
Journal:  J Virol       Date:  1981-11       Impact factor: 5.103

9.  Structural and functional dissection of an MHC class I antigen-binding adenovirus glycoprotein.

Authors:  S Pääbo; F Weber; T Nilsson; W Schaffner; P A Peterson
Journal:  EMBO J       Date:  1986-08       Impact factor: 11.598

10.  Different structural constraints for recognition of mouse H-2Kd and -Kk antigens by alloimmune cytolytic T lymphocytes.

Authors:  J Schøller; R Shimonkevitz; H R MacDonald; S Kvist
Journal:  J Exp Med       Date:  1986-12-01       Impact factor: 14.307

View more
  43 in total

Review 1.  Mechanisms of viral pathogenesis in rheumatic disease.

Authors:  A Perl
Journal:  Ann Rheum Dis       Date:  1999-08       Impact factor: 19.103

Review 2.  The multiple roles of major histocompatibility complex class-I-like molecules in mucosal immune function.

Authors:  R S Blumberg; Y van de Wal; S Claypool; N Corazza; B Dickinson; E Nieuwenhuis; R Pitman; G Spiekermann; X Zhu; S Colgan; W I Lencer
Journal:  Acta Odontol Scand       Date:  2001-06       Impact factor: 2.331

3.  Role of the adenovirus E3-19k conserved region in binding major histocompatibility complex class I molecules.

Authors:  P Flomenberg; J Szmulewicz; E Gutierrez; H Lupatkin
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

4.  The endoplasmic reticulum lumenal domain of the adenovirus type 2 E3-19K protein binds to peptide-filled and peptide-deficient HLA-A*1101 molecules.

Authors:  Hong Liu; Walter F Stafford; Marlene Bouvier
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

5.  Expression of gp19K increases the persistence of transgene expression from an adenovirus vector in the mouse lung and liver.

Authors:  J T Bruder; T Jie; D L McVey; I Kovesdi
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

6.  Determinants of the endoplasmic reticulum (ER) lumenal-domain of the adenovirus serotype 2 E3-19K protein for association with and ER-retention of major histocompatibility complex class I molecules.

Authors:  Jie Fu; Marlene Bouvier
Journal:  Mol Immunol       Date:  2010-11-20       Impact factor: 4.407

7.  Adenovirus E3/19K promotes evasion of NK cell recognition by intracellular sequestration of the NKG2D ligands major histocompatibility complex class I chain-related proteins A and B.

Authors:  Brian P McSharry; Hans-Gerhard Burgert; Douglas P Owen; Richard J Stanton; Virginie Prod'homme; Martina Sester; Katja Koebernick; Veronika Groh; Thomas Spies; Steven Cox; Ann-Margaret Little; Eddie C Y Wang; Peter Tomasec; Gavin W G Wilkinson
Journal:  J Virol       Date:  2008-02-20       Impact factor: 5.103

Review 8.  MHC class I antigen presentation: learning from viral evasion strategies.

Authors:  Ted H Hansen; Marlene Bouvier
Journal:  Nat Rev Immunol       Date:  2009-07       Impact factor: 53.106

9.  Homologous recombination in E3 genes of human adenovirus species D.

Authors:  Gurdeep Singh; Christopher M Robinson; Shoaleh Dehghan; Morris S Jones; David W Dyer; Donald Seto; James Chodosh
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

10.  Down-regulation of HLA antigens by the adenovirus type 2 E3/19K protein in a T-lymphoma cell line.

Authors:  H Körner; H G Burgert
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.